Parties Select a Dozen JUUL Injury Claims For Next Phase of Bellwether Trial Process

With more than 1,100 JUUL lawsuits pending in the federal court system, each involving allegations that the e-cigarette manufacturer caused widespread teen nicotine addiction problems by aggressively marketing the device to minors and prior non-smokers, parties involved in the litigation have identified a group of 12 injury claims for a “bellwether” discovery pool.

JUUL Labs has been accused of fueling the teen vaping epidemic which has emerged in the United States over the past few years, with a new generation of young adults now addicted to nicotine released by the devices. The company has been accused of intentionally targeting teens through social media marketing and other efforts which promoted the devices as safe.

The vape pens were sold in a variety of candy-like flavors intended to appeal to prior non-smokers, and the devices were designed to look like USB drives, allowing teens to hide their vaping habit from parents and school officials.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The litigation includes addiction injury claims brought on behalf of individuals nationwide, as well as a number of lawsuits filed on behalf of school districts, which have had to devote additional resources to prevent JUULing on campus and educate teens about the long-term health consequences of nicotine addiction.

Given similar questions of fact and law presented in complaints filed throughout the federal court system, the litigation has been centralized for discovery and pretrial proceedings before U.S. District Judge William H. Orrick III in the U.S. District Court for the Northern District of California, which is where JUUL Labs, Inc.’s San Francisco headquarters are located.

To help the parties gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout the litigation, Judge Orrick has previously indicated that a series of bellwether trials will be held involving claims that are representative of fact patterns presented in other cases.

On December 15, the parties issued a joint notice (PDF) announcing the 12 cases which have been randomly selected to make up the bellwether trial pool.

In late August, Judge Orrick indicated the first bellwether trials will begin in February 2022, following a case-specific discovery process and future challenges to the admissibility of expert witness testimony.

While the outcomes of these early bellwether trials will not be binding on other claims pending in the federal court system, they will be closely watched and may greatly influence any JUUL settlements offered by the manufacturer to avoid the need for hundreds of individual trial dates in the coming years.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.

Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant
Abbott Laboratories Faces Jury Trial Over Claims Similac Caused NEC For Premature Infant (Posted 2 days ago)

Following a $60 million verdict in a similar lawsuit earlier this year, trial is underway involving claims brought by an Illinois mother, whose premature daughter developed NEC from Similac, alleging that Abbott failed to warn parents and medical staff of the devastating risks associated with the cow's milk-based formula.